Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC January Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Allergen extract of phleum pratense (Grazax®) has been rejected following a resubmission. Despite some modest clinical benefit the economic analysis was insufficiently robust to gain acceptance.

Beclometasone / formoterol metered dose inhaler (Fostair®) has been accepted for use in the treatment of asthma where a combination product is appropriate. This would be Step 3 of the British Thoracic Society Asthma Guidelines.

Latanoprost and timolol eye drops (Xalacom®) has been accepted for the treatment of raised intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Share 'SMC January Update' on Email Share 'SMC January Update' on Delicious Share 'SMC January Update' on Digg Share 'SMC January Update' on Facebook Share 'SMC January Update' on Google+ Share 'SMC January Update' on reddit Share 'SMC January Update' on StumbleUpon Share 'SMC January Update' on Twitter

atomic-wealth

No Comments to “SMC January Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,668 spam comments.

atomic-wealth
fond-illness
summer